Tinning Craig G, Cochrane Lynda A, Singer Brian R
Department of Orthopaedic and Trauma Surgery, Ninewells Hospital, Dundee, UK.
Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, UK.
Injury. 2015 Jul;46(7):1328-32. doi: 10.1016/j.injury.2015.03.035. Epub 2015 Apr 9.
Hyponatraemia is common in hospitalised patients. In recent years the relationship between hyponatraemia and bone metabolism, falls and fractures has become more established. This study evaluates the prevalence of hyponatraemia (plasma sodium<135mmol/l) in 3897 patients undergoing operative treatment for hip fracture and the relationship between hyponatraemia and mortality in these patients. Hyponatraemia was an independent risk factor for increased post-operative mortality on multivariate analysis. Median age at admission was 83 years. Hyponatraemia was present in 19.1% of patients with hip fracture on admission, 29.5% of patients in the first 24h post-operatively and 20% of patients at discharge. There was a significant association between hyponatraemia and time from admission to surgery indicating that patients admitted with hyponatraemia waited longer. The median follow-up time was 863 (range 0-4352) days. There were 2460 deaths (63.1% of the original 3897 patients) prior to the censor date. A total of 1144 patients (29.4% of the original 3897 patients) died within 12 months of discharge. Median time to death for patients with and without hyponatraemia on admission was 34 months (SE 1.7 months) and 41 months (SE 2.5 months) respectively (p=0.003). Median time to death for patients with and without hyponatraemia within 24h post-operatively was 35 months (SE 2.5 months) and 42 months (SE 1.7 months) respectively (p=0.004). Following elimination of other independent variables associated with increased mortality, hyponatraemia on admission was associated with an increased risk of death (adjusted HR 1.15, p=0.005). Post-operative hyponatraemia was also associated with an increased risk of death (adjusted HR 1.15, p=0.006). Trends suggested that hyponatraemia within 48h of discharge was associated with an increased risk of death (adjusted HR 1.15, p=0.636). Hyponatraemia is common in elderly patients with hip fractures both at initial presentation and during admission. In this vulnerable patient group, hyponatraemia may delay time to definitive surgery and is a potentially reversible cause of increased post-operative mortality. Every effort should be made to identify and correct hyponatraemia in hip fracture patients.
低钠血症在住院患者中很常见。近年来,低钠血症与骨代谢、跌倒和骨折之间的关系已得到更充分的确立。本研究评估了3897例接受髋部骨折手术治疗患者的低钠血症(血浆钠<135mmol/L)患病率以及低钠血症与这些患者死亡率之间的关系。多因素分析显示,低钠血症是术后死亡率增加的独立危险因素。入院时的中位年龄为83岁。入院时19.1%的髋部骨折患者存在低钠血症,术后24小时内为29.5%,出院时为20%。低钠血症与入院至手术的时间之间存在显著关联,表明入院时患有低钠血症的患者等待时间更长。中位随访时间为863天(范围0 - 4352天)。在 censoring 日期之前有2460例死亡(占最初3897例患者的63.1%)。共有1144例患者(占最初3897例患者的29.4%)在出院后12个月内死亡。入院时患有和未患有低钠血症的患者的中位死亡时间分别为34个月(标准误1.7个月)和41个月(标准误2.5个月)(p = 0.003)。术后24小时内患有和未患有低钠血症的患者的中位死亡时间分别为35个月(标准误2.5个月)和42个月(标准误1.7个月)(p = 0.004)。在排除与死亡率增加相关的其他独立变量后,入院时的低钠血症与死亡风险增加相关(调整后风险比1.15,p = 0.005)。术后低钠血症也与死亡风险增加相关(调整后风险比1.15,p = 0.006)。趋势表明,出院后48小时内的低钠血症与死亡风险增加相关(调整后风险比1.15,p = 0.636)。低钠血症在老年髋部骨折患者初次就诊时和住院期间都很常见。在这个脆弱的患者群体中,低钠血症可能会延迟确定性手术的时间,并且是术后死亡率增加的一个潜在可逆转原因。应尽一切努力识别并纠正髋部骨折患者的低钠血症。